Yusuf Y Deeni

2PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 01, 2022
Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors.

Ibrahim H Kankia, Poornima Paramasivan, Matthew Elcombe

|Feb 08, 2018
NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib.

Ibrahim H Kankia, Hilal S Khalil, Simon P Langdon

Pageof 1